title: Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
abstract: Penciclovir (PCV), an antiherpesvirus agent in the same class as acyclovir (ACV), is phosphorylated in herpes simplex virus (HSV)-infected cells by the viral thymidine kinase (TK). Resistance to ACV has been mapped to mutations within either the TK or the DNA polymerase gene. An identical activation pathway, the similarity in mode of action, and the invariant cross-resistance of TK-negative mutants argue that the mechanisms of resistance to PCV and ACV are likely to be analogous. A total of 48 HSV type 1 (HSV-1) and HSV-2 isolates were selected after passage in the presence of increasing concentrations of PCV or ACV in MRC-5 cells. Phenotypic analysis suggested these isolates were deficient in TK activity. Moreover, sequencing of the TK genes from ACV-selected mutants identified two homopolymeric G-C nucleotide stretches as putative hot spots, thereby confirming previous reports examining Acv(r) clinical isolates. Surprisingly, mutations identified in PCV-selected mutants were generally not in these regions but distributed throughout the TK gene and at similar frequencies of occurrence within A-T or G-C nucleotides, regardless of virus type. Furthermore, HSV-1 isolates selected in the presence of ACV commonly included frameshift mutations, while PCV-selected HSV-1 mutants contained mostly nonconservative amino acid changes. Data from this panel of laboratory isolates show that Pcv(r) mutants share cross-resistance and only limited sequence similarity with HSV mutants identified following ACV selection. Subtle differences between PCV and ACV in the interaction with viral TK or polymerase may account for the different spectra of genotypes observed for the two sets of mutants.
authors.affiliation: Molecular Virology and Host Defense, SmithKline Beecham Pharmaceuticals, Collegeville, Pennsylvania 19426-0989, USA. robert_t_sarisky@sbphrd.com
authors.forename: R T
authors.initials: RT
authors.lastname: Sarisky
authors.forename: M R
authors.initials: MR
authors.lastname: Quail
authors.forename: P E
authors.initials: PE
authors.lastname: Clark
authors.forename: T T
authors.initials: TT
authors.lastname: Nguyen
authors.forename: W S
authors.initials: WS
authors.lastname: Halsey
authors.forename: R J
authors.initials: RJ
authors.lastname: Wittrock
authors.forename: J
authors.initials: J
authors.lastname: O'Leary Bartus
authors.forename: M M
authors.initials: MM
authors.lastname: Van Horn
authors.forename: G M
authors.initials: GM
authors.lastname: Sathe
authors.forename: S
authors.initials: S
authors.lastname: Van Horn
authors.forename: M D
authors.initials: MD
authors.lastname: Kelly
authors.forename: T H
authors.initials: TH
authors.lastname: Bacon
authors.forename: J J
authors.initials: JJ
authors.lastname: Leary
mesh_terms: D000212:Acyclovir / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001345:Autoradiography; D002460:Cell Line; D004279:DNA, Viral / Q000235:genetics; D004352:Drug Resistance, Microbial; D006147:Guanine; D018259:Herpesvirus 1, Human / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D018258:Herpesvirus 2, Human / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D006801:Humans; D009154:Mutation; D017422:Sequence Analysis, DNA; D013937:Thymidine Kinase / Q000235:genetics / Q000378:metabolism; D010948:Viral Plaque Assay
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; C053539:penciclovir; D006147:Guanine; D013937:Thymidine Kinase; D000212:Acyclovir